Michael R. Robinson
67Patents
13h-index
79Co-inventors
87Inventor score
Filing activity: May 20, 1996 → Feb 14, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6713081B2 | Ocular therapeutic agent delivery devices and methods for making and using such devices | Emerging Cross-Sectional Technologies | 272 | Expired |
| US5706649A | Multi axis thrust vectoring for turbo fan engines | Emerging Cross-Sectional Technologies | 43 | Expired |
| US7658364B2 | Ocular therapeutic agent delivery devices and methods for making and using such devices | Emerging Cross-Sectional Technologies | 40 | Expired |
| US8647659B2 | Intracameral sustained release therapeutic agent implants | Human Necessities | 39 | Active |
| US8821870B2 | Method for treating atrophic age related macular degeneration | Human Necessities | 38 | Active |
| US6990179B2 | Speech recognition method of and system for determining the status of an answered telephone during the course of an outbound telephone call | Electricity | 36 | Expired |
| US8571802B2 | Method for determining optimum intraocular locations for drug delivery systems | Human Necessities | 28 | Active |
| US9050336B2 | Botulinum toxin formulation | Chemistry; Metallurgy | 23 | Active |
| US9044477B2 | Botulinum toxin formulation | Chemistry; Metallurgy | 19 | Active |
| US5984229A | Extremely short takeoff and landing of aircraft using multi-axis thrust vectoring | Emerging Cross-Sectional Technologies | 18 | Expired |
| US10780218B2 | Intraocular implant delivery apparatus and methods of use thereof | Human Necessities | 14 | Active |
| US10610518B2 | Presbyopia treatments | Human Necessities | 13 | Active |
| US8969415B2 | Intraocular drug delivery systems | Human Necessities | 13 | Active |
| US8846094B2 | Peripherally administered viscous formulations | Human Necessities | 12 | Active |
| US9061065B2 | Intracameral sustained release therapeutic agent implants | Human Necessities | 12 | Active |
| US9161970B2 | Dermal filler | Emerging Cross-Sectional Technologies | 11 | Active |
| US9089478B2 | Peripherally administered viscous formulations | Human Necessities | 9 | Active |
| US9095506B2 | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof | Human Necessities | 9 | Active |
| US9522113B2 | Biodegradable alpha-2 agonist polymeric implants and therapeutic uses thereof | Human Necessities | 8 | Active |
| US9313312B2 | Speech recognition method of and system for determining the status of an answered telephone during the course of an outbound telephone call | Electricity | 8 | Active |
| US8231892B2 | Biodegradable drug delivery system | Human Necessities | 7 | Active |
| US8956655B2 | Biodegradable drug delivery system | Human Necessities | 7 | Active |
| US10278919B2 | Intracameral sustained release therapeutic agent implants | Human Necessities | 6 | Active |
| US9504696B2 | Intracameral sustained release therapeutic agent implants | Human Necessities | 6 | Active |
| US9492316B2 | Prostamide-containing intraocular implants and methods of use thereof | Human Necessities | 6 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.